Search Prime Grants

HT94252310280

Project Grant

Overview

Grant Description
Development of a rapid, non-addictive, intranasal treatment for headache disorders.
Awardee
Olfax
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Asheville, North Carolina 288035088 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Olfax was awarded Rapid, Non-Addictive Intranasal Treatment for Headache Disorders Project Grant HT94252310280 worth $5,598,503 from Defense Health Agency in April 2023 with work to be completed primarily in Asheville North Carolina United States. The grant has a duration of 2 years 9 months and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 4/27/23

Period of Performance
4/15/23
Start Date
1/14/26
End Date
94.0% Complete

Funding Split
$5.6M
Federal Obligation
$0.0
Non-Federal Obligation
$5.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252310280

Additional Detail

Award ID FAIN
HT94252310280
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
TVWUUJVHAD33
Awardee CAGE
8WCV8
Performance District
11
Senators
Thom Tillis
Ted Budd
Representative
Charles (Chuck) Edwards

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $5,598,503 100%
Modified: 4/27/23